Tim Opler

Dr. Timothy Opler is a Co-Founder of Bond Biosciences. Dr. Opler raised the Seed Round of investment and provides ongoing financial support for the company.

He is a Partner and Co-Founder of Torreya, a global boutique investment banking firm serving companies in the life sciences industry.

Dr. Opler has 24 years of experience leading strategic and financing transactions across multiple sectors. For nearly 20 years, he has focused exclusively on the life sciences sector and has completed more than 150 financings, licensing, and merger and acquisition (M&A) transactions across the industry, with a total value of over $100 billion. Highlights include running the largest share buyback in history for Pfizer, leading a $3.9 billion convertible bond exchange for Amgen, working on Chiron’s $5.1 billion sale to Novartis, and managing Genentech’s inaugural $2 billion bond issue.

Before co-founding Torreya, Dr. Opler was Vice President of Strategy at FibroGen, where he helped raise $117 million for the company and negotiated licensing deals. Previously, he was a Managing Director in Healthcare Investment Banking at Credit Suisse First Boston and held senior roles at W.R. Hambrecht, Deutsche Bank, and Merrill Lynch.